Literature DB >> 16635616

Effects of statins on renal function after aortic cross clamping during major vascular surgery.

Olaf Schouten1, Niels F M Kok, Eric Boersma, Jeroen J Bax, Harm H H Feringa, Radosav Vidakovic, Randolph G Statius van Eps, Marc R H M van Sambeek, Don Poldermans.   

Abstract

Ischemic reperfusion injury is an important cause of renal dysfunction after major vascular surgery and increases postoperative morbidity and mortality. The aim of the present study was to assess the effect of statins on renal function in patients at high risk for renal dysfunction, that is, those who underwent suprarenal aortic cross clamping-declamping. Seventy-seven patients (28 statin users, 57 men; mean age 69 +/- 8 years) with normal preoperative renal function requiring suprarenal aortic cross clamping-declamping during vascular surgery from 1995 to 2005 were studied. Creatinine levels were obtained before surgery and on days 1, 2, 3, 7, and 30 after surgery. An analysis-of-variance model for repeated measurements was applied to compare creatinine levels between statin users and nonusers, with adjustment for clamping time and blood loss. There were no differences in baseline clinical characteristics, preoperative creatinine levels (0.93 vs 0.96 mg/dl, p = 0.59), and glomerular filtration rate (79 vs 73 ml/min, p = 0.1). Postoperative creatinine levels during the 30 days after surgery were significantly lower in statin users than in nonusers (analysis-of-variance p <0.01, 1.17 vs 1.98 mg/dl). Postoperative hemodialysis was required (temporarily) in 7 patients (9.1%), all statin nonusers. These findings suggest an association between statin use and preserved renal function after suprarenal aortic clamping.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16635616     DOI: 10.1016/j.amjcard.2005.11.063

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  6 in total

1.  Statin use associates with a lower incidence of acute kidney injury after major elective surgery.

Authors:  Amber O Molnar; Steven G Coca; Phillip J Devereaux; Arsh K Jain; Abhijat Kitchlu; Jin Luo; Chirag R Parikh; J Michael Paterson; Nausheen Siddiqui; Ron Wald; Michael Walsh; Amit X Garg
Journal:  J Am Soc Nephrol       Date:  2011-04-14       Impact factor: 10.121

2.  Early postoperative statin therapy is associated with a lower incidence of acute kidney injury after cardiac surgery.

Authors:  Frederic T Billings; Mias Pretorius; Edward D Siew; Chang Yu; Nancy J Brown
Journal:  J Cardiothorac Vasc Anesth       Date:  2010-12       Impact factor: 2.628

3.  Statin administration did not influence the progression of lung injury or associated organ failures in a cohort of patients with acute lung injury.

Authors:  Daryl J Kor; Remzi Iscimen; Murat Yilmaz; Michael J Brown; Daniel R Brown; Ognjen Gajic
Journal:  Intensive Care Med       Date:  2009-01-31       Impact factor: 17.440

Review 4.  Perioperative use of statins in noncardiac surgery.

Authors:  Y C Chan; S W Cheng; M G Irwin
Journal:  Vasc Health Risk Manag       Date:  2008

5.  Atorvastatin treatment attenuates renal injury in an experimental model of ischemia-reperfusion in rats.

Authors:  Kefei Wu; Wenjing Lei; Jianwei Tian; Hongyan Li
Journal:  BMC Nephrol       Date:  2014-01-15       Impact factor: 2.388

6.  Atorvastatin and prevention of contrast induced nephropathy following coronary angiography.

Authors:  Peyman Bidram; Farshad Roghani; Hamid Sanei; Zahraparin Hedayati; Allahyar Golabchi; Mehdi Mousavi; Alireza Hajiannejad; Behrouz Pourheidar; Mehdi Mohseni Badalabadi; Maryam Gharaati; Mohammadreza Akhbari; Asieh Salesi
Journal:  J Res Med Sci       Date:  2015-01       Impact factor: 1.852

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.